Navigation Links
Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
Date:1/27/2009

-hGH-CTP Development Program Has Been Approved For Second-Year Funding Through a Special Grant From the Israeli Office of the Chief Scientist-

NES-ZIONA, Israel, Jan. 27 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today reported that its Israeli-based R&D subsidiary has received approval for a second-year special grant from the Israeli Office of the Chief Scientist ("OCS") in support of the company's development program for hGH-CTP, its longer-acting version of human growth hormone (hGH). The new grant follows the company's recent announcement of promising results from a pilot hGH-CTP toxicity study in primates.

The OCS has approved this second-year grant to support Modigene's hGH-CTP program for the period September 2008 through August 2009. The grant will provide cash reimbursements of 40% of expenses paid for hGH-CTP product development during this period, up to a limit of 10 million NIS (about $2.6 million).

Human growth hormone is a natural protein produced by the pituitary gland in the brain. It fuels growth of the body's bone and muscle and has a variety of therapeutic uses. Patients with an hGH deficiency currently receive subcutaneous hGH injections on a near-daily basis. Approximately 95% of children diagnosed with a growth hormone deficiency receive treatment. The current annual market for hGH therapies is estimated at $2.5 billion.

"This second-year grant from the OCS is an important non-dilutive cash resource for Modigene and represents another validation of the potential of our technology and of our lead candidate hGH-CTP," said Abraham Havron, Ph.D., Chief Executive Officer of Modigene. "The OCS has awarded Modigene funds in support of both our hGH-CTP product candidate and our IFN-Beta-CTP longer-acting interferon product, and we are delighted that our longer-acting human growth program has been chosen for continued support out of many strong
'/>"/>

SOURCE Modigene Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Modigene to Present at the UBS Global Life Sciences Conference
2. Modigene to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
3. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
4. Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. Modigene to Present at the Roth 2007 New York Investor Conference
6. Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics
7. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
8. Probiotic Delivery Technology Awarded Third International Patent
9. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
10. China Medicine Corporation Awarded GSP Certification
11. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...d blue dye test alternative is helping bring com...e step closer for pharma-companies. It is a non-de...loped by Sepha for use with blister packs and it...lobal pharma-companies such as Sanofi-Avenis and Z...uctivity improvements on the packaging line. Bli...
(Date:11/25/2009)...to Speak at Economic Club of Canada , ...2009 -- Ambassador to Speak at Economic Club of Ca...r for International Investment, and Chairman and C...aphy of David Appia go to www.investinfrance.org ...et with press to discuss recent pro-business initi...
(Date:11/25/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Brazil Bioethanol Market Analysis an...r.com/p0165503/Brazil-Bioethanol-Market-Analysis-a... Market Analysis and Forecasts to 2013 ,, Summ...nd forecasts of the global bioethanol market and t...
(Date:11/24/2009)...to also Visit Detroit , (... French Ambassador for International Investment, a..., , , , ,What: Ambassador Appia is available to m...iatives adopted by France to further develop the f...tion and development., , ,When: Available for Inte...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3French Ambassador for International Investment to Visit Toronto December 11 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
...on Area Technical College would like to see more ... ,Over the last decade, the percentage of women in... to 32 percent, said Janet Kelly, communications d... in IT programs has dropped to under 20 percent. ,...e on Wednesday was Patricia Prime, chief informati...
...d Imaxio S.A. (Saint-Beauzire, France) have fina...ide rights to manufacture and sell OverExpress b...der the agreement, Imaxio will retain the right to...al applications, but Lucigen will provide the cell...ired for research use of OverExpress cells by non-...
.... In addition to being big business (untold billio...us ethical issues and choices. We are all aware of...nsent underlying all clinical trials. , ,What is...carries with it the responsibility to obtain and s...ve or even if the clinical trial is a failure. It ...
Other Biology Technology:MATC seeks to turn around falling tech enrollment among women 2Lucigen Corp. enters global licensing agreement 2What patients want: A story of choice, clinical trials & evidence-based medicine 2What patients want: A story of choice, clinical trials & evidence-based medicine 3What patients want: A story of choice, clinical trials & evidence-based medicine 4What patients want: A story of choice, clinical trials & evidence-based medicine 5
(Date:11/25/2009)..., police officers and ambulance workers faced a te...omplex. They battled to save people from the colla... fires and evacuated as many people as they could ...ple. And making their jobs even harder was the pro...d their relatives jammed mobile networks with call...
(Date:11/25/2009)...istant professors recently received funding from t...esearch beneficial to understanding the environmen...r Blackwood, assistant professor in the Department...port two separate research projects. , His first...munities and Functions from the Leaf to the Landsc...
(Date:11/24/2009)... doors to understanding how sounds associated with...ammal or if they hear it at all. , The same typ...SA uses to detect flaws in the space shuttle,s beh...s to peek inside the giant head of a whale. The sc...cas of a whale,s hearing anatomy using a breakthro...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 1Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 2Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 3Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 4Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 5Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 6Reportlinker Adds Reinventing Pharmaceutical Sales Forces 5334 7Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 1Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 2Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 3A study to prevent sudden death in sports by means of genetic testing 59151 1A study to prevent sudden death in sports by means of genetic testing 59151 2
...k about house calls! The Wildlife Conservation Soc...ad To Early Detection" campaign for their assistan...Bronx Zoo. , The on-site procedureperformed by d...edical personnel from several institutionswas made...8-foot-long MRI facility on wheels that conducted ...
...IS, CALIF.A new drug developed at the University o...n and inflammatory has entered Phase II of human c...ompound, a soluble epoxide hydrolase enzyme (s-EH)...eat a suite of major cardiovascular and metabolic ...th UC Berkeley cell biologist Sarjeet Gill discove...
...emarkable new invention from Tel Aviv University ...led "Smart Dew" will foil even the most determine...sts and doorways, or indoors on the floor of a ban...ctive system for safeguarding and securing wide sw...Tel Aviv University Faculty of Engineering team dr...
Other Biology News:Gorilla gets MRI at Bronx Zoo 2Gorilla gets MRI at Bronx Zoo 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 2UC Davis bench-to-bedside research: Promising treatment in clinical trials 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 4UC Davis bench-to-bedside research: Promising treatment in clinical trials 5Intruder alert: Tel Aviv University's 'Smart Dew' will find you! 2
Bovine TNP-BGG (Bovine Gamma Globulin), BGG (Bovine Gamma Globulin) conjugated/tagged from Biosearch Technologies
Equine TNF-alpha (TNFSF1A) ELISA development Kit, DuoSet from R&D Systems
Creatinine Colorimetric Assay Kit from R&D Systems
Equine IL-4 from AbD Serotec
Biology Products: